Literature DB >> 1429891

Formation of skeletal muscle in vivo from the mouse C2 cell line.

J E Morgan1, S E Moore, F S Walsh, T A Partridge.   

Abstract

The C2 muscle cell line is myogenic in vitro and has been extensively used in studies of muscle cell differentiation. Here, we have investigated the myogenicity in vivo of C2 cells implanted into suitable sites in the mouse. Large amounts of new muscle were formed when C2 cells were implanted into sites in nude mice which were undergoing regeneration following whole muscle grafting and in scaffolding of freeze-killed muscle or vicryl suture in the anterior tibial compartment. When implanted into regenerating muscle, C2 cells fused with the host muscle to form mosaic fibres; when implanted into inert sites, they formed muscle of largely donor origin. C2-derived muscle fibres appeared to become innervated, but the progression of N-CAM (neural cell adhesion molecule) isoform changes in such regenerates indicated that they did not become fully mature. Proliferating, undifferentiated cells of C2 origin form tumours in older grafts; however, this was more pronounced in the absence of competition from host muscle cells. In the short term, C2 cells can form large amounts of muscle in vivo for biochemical analysis. In addition, C2 cells are easily manipulable in vitro; genes of interest may be transfected into them prior to implantation of the cells into skeletal muscle and the effects of these genes in vivo may thus be examined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429891     DOI: 10.1242/jcs.102.4.779

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

Review 1.  The H-2KbtsA58 transgenic mouse: a new tool for the rapid generation of novel cell lines.

Authors:  M Noble; A K Groves; P Ataliotis; Z Ikram; P S Jat
Journal:  Transgenic Res       Date:  1995-07       Impact factor: 2.788

2.  Dystrophin-positive muscle fibers following C2 myoblast transplantation into mdx nude mice.

Authors:  Y Hagiwara; Y Mizuno; M Takemitsu; T Matsuzaki; I Nonaka; E Ozawa
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  A new extensively characterised conditionally immortal muscle cell-line for investigating therapeutic strategies in muscular dystrophies.

Authors:  Sofia Muses; Jennifer E Morgan; Dominic J Wells
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

4.  Intramuscular Transplantation of Muscle Precursor Cells over-expressing MMP-9 improves Transplantation Success.

Authors:  Christophe Pichavant; Cesare Gargioli; Jacques P Tremblay
Journal:  PLoS Curr       Date:  2011-10-26

5.  Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site.

Authors:  Jennifer E Morgan; Jacqueline G Gross; Charles N Pagel; Jonathan R Beauchamp; Ariberto Fassati; Adrian J Thrasher; James P Di Santo; Ivan B Fisher; Xu Shiwen; David J Abraham; Terence A Partridge
Journal:  J Cell Biol       Date:  2002-05-13       Impact factor: 10.539

6.  RNA-Seq analysis of a Pax3-expressing myoblast clone in-vitro and effect of culture surface stiffness on differentiation.

Authors:  Louise Richardson; Dapeng Wang; Ruth Hughes; Colin A Johnson; Michelle Peckham
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.379

7.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.

Authors:  T A Rando; H M Blau
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

8.  Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.

Authors:  J T Vilquin; I Kinoshita; B Roy; M Goulet; E Engvall; F Tomé; M Fardeau; J P Tremblay
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

9.  Peripherin expression in hippocampal neurons induced by muscle soluble factor(s).

Authors:  K Djabali; A Zissopoulou; M J de Hoop; S D Georgatos; C G Dotti
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.